What does MOMS mean in CLINICAL MEDICINE
MOMS stands for Management of Myelomeningocele Study. It is a research study designed to evaluate the effectiveness of different surgical interventions for myelomeningocele, a birth defect that affects the spinal cord. The study was initiated in 2003 and has enrolled over 1,000 infants with myelomeningocele.
MOMS meaning in Clinical Medicine in Medical
MOMS mostly used in an acronym Clinical Medicine in Category Medical that means Management of myelomeningocele study
Shorthand: MOMS,
Full Form: Management of myelomeningocele study
For more information of "Management of myelomeningocele study", see the section below.
Key Objectives
- Compare the outcomes of early versus delayed surgical repair of myelomeningocele.
- Determine the optimal timing and technique for surgical intervention.
- Evaluate the impact of surgery on neurologic function, cognitive development, and quality of life.
Methodology
MOMS is a multicenter, randomized controlled trial. Infants with myelomeningocele are randomly assigned to either early surgical repair (within 24 hours of birth) or delayed surgical repair (after 48 hours of birth). The study follows the participants for several years to assess their outcomes.
Results
Preliminary results from MOMS have shown that early surgical repair is associated with improved neurologic function and cognitive development. However, the study is ongoing, and further research is needed to confirm these findings and determine the long-term outcomes of early versus delayed surgical repair.
Essential Questions and Answers on Management of myelomeningocele study in "MEDICAL»CLINICAL"
What is the Management of Myelomeningocele Study (MOMS)?
MOMS is a large, international clinical trial that aims to improve the outcomes of babies born with myelomeningocele, a serious birth defect that affects the spinal cord.
What are the goals of MOMS?
MOMS aims to:
- Determine the best timing for fetal surgery to repair myelomeningocele.
- Evaluate the effectiveness of different surgical techniques.
- Identify the best ways to manage associated conditions, such as hydrocephalus and Chiari II malformation.
Who is eligible to participate in MOMS?
Pregnant women with a fetus diagnosed with myelomeningocele are eligible to participate.
What are the potential benefits of participating in MOMS?
Participating in MOMS may provide access to the latest treatments and surgical techniques, which could improve outcomes for both the mother and baby.
What are the potential risks of participating in MOMS?
As with any medical intervention, there are potential risks associated with participating in MOMS. These risks will be discussed in detail with participants before they make a decision about joining the study.
How long will the study last?
MOMS is a long-term study that will follow participants for several years to assess the long-term outcomes of fetal surgery and other treatments.
Where can I find more information about MOMS?
For more information, please visit the MOMS website or contact your healthcare provider.
Final Words: MOMS is a landmark study that has the potential to improve the outcomes of infants with myelomeningocele. The results of the study will help clinicians make informed decisions about the optimal timing and technique for surgical intervention.
MOMS also stands for: |
|
| All stands for MOMS |